Endo Launches Generic Version of Afinitor® (everolimus) Tablets in the United States
Endo International plc - Ordinary Shares (ENDP)
Last endo international plc - ordinary shares earnings: 2/26 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.endo.com/newsroom/news-releases
Company Research
Source: PR Newswire
DUBLIN, Dec. 10, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that one of its operating companies, Par Pharmaceutical (Par), has received approval for and launched generic Afinitor® (everolimus) 2.5 mg, 5 mg and 7 mg tablets. Product is available for immediate shipping."We are pleased to bring the first generic Afinitor® to market and provide patients with a lower-cost option," said Domenic Ciarico, Executive Vice President & Chief Commercial Officer, Sterile & Generics at Endo. "This launch is a testament to Par's expertise in manufacturing technically challenging products while maintaining excellence in quality."According to IQVIA data, sales for Afinitor® 2.5 mg, 5mg and 7mg tablets were approximately $412 million over the last four quarters. Afinitor® is a registered trademark of Novartis AG.About Endo International plc Endo International plc (NASDAQ: ENDP) is a highly focused generics and specialty branded pharmaceuticals company delivering quality m
Show less
Read more
Impact Snapshot
Event Time:
ENDP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ENDP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ENDP alerts
High impacting Endo International plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics